Global C-Reactive Protein Testing Market Size & Analysis - Forecasts To 2026

1. Global C-Reactive Protein Testing Market Size & Analysis - By Detection Range (HS- CRP, CCRP, Conventional CRP), By Assay Type (ELISA, Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assay, Others), By Disease Type (Inflammatory Bowel Disease, Endometriosis, Cancer, Rheumatoid Arthritis, Cardiovascular Diseases, Lupus, Others), By Application (Hospitals And Clinics, Laboratories, Assisted Living Healthcare Facilities, Others), By Region (North America, Europe, Asia-Pacific, CSA, MEA)- Forecasts to 2026 C-Reactive Protein Testing Market Opportunities: Rise in adoption of point of care devices: Point of care testing or bedside testing essentially involves medical diagnostic testing near the point of care. This kind of testing is aimed at facilitating easy, fast and convenient diagnosis. The newest points of care devices are easy to use by patients. They are used to monitor levels of inflammatory proteins in the patient. The paper based tests are able to measure serum stain length inside the paper. These tests take approximately 5 minutes to get results as opposed to lab-based CRP tests which take several hours. Point of care testing devices use the wax printing method to define hydrophobic boundaries, it also reduces cost involved in manufacturing & operations. Government institutions are actively supporting adoption of point of care devices in medical facilities and promoting development of new technology. In July 2018, NHS England announced that they will be introducing point of care diagnostic devices in General practice. Use of these devices in general practice diagnostics is expected to bring down prescription of antibiotics substantially. Request for a sample copy of the report @:https://www.globalmarketestimates.com/report- summary.php?report_id=1975&report_name=global-c-reactive-protein-testing-market C-Reactive Protein Testing Market Challenges: Availability of alternative tests with higher accuracy: The major challenge faced by the C-reactive protein market is technological advancement and development of newer tests which provide more efficient and accurate results. The ESR (Erythrocyte Sedimentation Rate) test is widely used as a marker for measuring inflammation along with the CSP test. ESR is useful in monitoring and diagnosing chronic diseases. Further, neither the CRP not ESR test is a definitive diagnostic test to conclude the patient diagnosis. A combination of multiple blood and physical tests are necessary to reach a diagnosis. Due to these reasons, general practitioners and medical facilities prefer using more advanced blood tests to improve their diagnosis and reduce lag time. Availability of advanced tests with improved accuracy is therefore expected to be a challenge for growth in the C-reactive protein testing market. Browse the complete report @:https://www.globalmarketestimates.com/report- summary.php?report_id=1975&report_name=global-c-reactive-protein-testing-market